The article focuses on three research papers reporting breakthrough in Hepatitis C Virus (HCV) by replicating full length HCV clones, which resulted in the development of effective antiviral therapies and vaccines. One of the papers was prepared by researchers from Wakita Co. who has developed an in vitro system, which replicates a subgenomic RNA that has not acquired any adaptive mutations.